Business Standard

Thursday, December 19, 2024 | 06:40 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

WHO issues a 'medical product alert' for Marion Biotech cough syrup

The WHO has said Marion Biotech had not provided guarantees to them on the safety and quality of these products

World Health Organisation, WHO
Premium

Sub-standard medical products are products that fail to meet quality standards or specifications and are therefore “out of specification”.

Sohini Das Mumbai
The World Health Organization (WHO) has issued a “medical product alert” for two sub-standard products made by Noida-based Marion Biotech — Ambronol syrup and DOK-1 Max syrup.
 
Marion Biotech’s cough syrup was linked to the death of 18 children in Uzbekistan. Following the development, the Indian drug regulator has been in touch with the Uzbekistan drug regulator. The production at the factory site has been stopped, and the Uttar Pradesh Food Safety and Drug Administration (FSDA) has also suspended the company’s licence.
 
This WHO Medical Product Alert refers to two sub-standard (contaminated) products, identified in Uzbekistan and reported to WHO

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in